Login to Your Account



Pharma: Clinic Roundup


Friday, September 6, 2013
Mallinckrodt Pharmaceuticals, of St. Louis, reported positive results from a Phase III trial of MNK-795 in acute pain following bunionectomy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription